3rd Albrecht Müller Seminar (free online conference)

on ‘Human Therapeutic Applications of Gene Editing’

November 13th, 2023 – 2pm-5pm (CET) – Paris time


Following our 1st ARRIGE webinar in honor of Albrecht Müller, and our 2nd ARRIGE webinar on Gene Drive and the various applications of genome editing technologies in Animals, Livestock & Pets, ARRIGE now invites you to our 3rd Albrecht Müller webinar that will focus on the applications of genome editing technologies in human therapeutics. Several examples will be presented in the treatment of cancer, infectious and eye diseases, followed by a roundtable addressing the various ethical and social issues at stake.

With: Lluis Montoliu (ARRIGE President, Spain), François Hirsch (ARRIGE Board, France), André Choulika (CEO, Cellectis, France), Deniz Dalkara (Inserm, France), Michael Santos (F.N.I.H. & ARRIGE Scientific Committee, USA), Jennifer Merchant (ARRIGE Board, France), Katherine Littler (Global Health Ethics & Governance Unit, WHO), Alta Charo (University of Wisconsin–Madison & Vice-President, ARRIGE Scientific Committee, USA), Donrich Willem Thaldar (University KwaZulu-Natal, South Africa), and Julian Kinderlerer (Former President, European Group on Ethics (EGE), & ARRIGE Board, South-Africa.

Free attendance but registration required through this link.

The ARRIGE association was launched in 2018 to promote a global governance of genome editing through a comprehensive setting for all stakeholders, including academics, researchers, clinicians, public institutions, private companies, patient organizations and other non-governmental organizations, regulators, citizens, communication media, governmental agencies and decision makers. It also aims to push forward the scientific, ethical, social, legal and political reflection in the field of genome editing, and foster the development of genome editing technologies within a safe and ethical framework for individuals and for our societies. A final objective is the dissemination of reliable information regarding genome-editing technology for experts (all fields included), politicians and citizens throughout the world.

*Albrecht Müller was Professor at the Institute of Medical Radiation and Cell Research at the University of Würzburg and was our link with the Berlin-Brandenburg Academy of Sciences and Humanities. Albrecht Müller was an early and active supporter of the concept and aims of ARRIGE and, as such, he contributed to its launching in early 2018, up to his untimely death in September 2019.

PURPOSE: The purpose of the Albrecht Müller’s ARRIGE Seminars is twofold. From a general standpoint, its mission is to provide a forum for ARRIGE members and followers to update their knowledge on the scientific and ethical issues of a particular topic linked to gene editing. Secondly, and above all, the seminar seeks to serve as a repository for new insight and policy recommendations by our members on the topic treated in the seminar.

SCOPE: This three-hour seminar aims at addressing both the scientific and societal issues which arise in application of genome editing to Human diseases. It will begin with the presentation of different applications. The rest of the seminar will be devoted to an open roundtable that will explore the ethical, social, environmental, economic and political ramifications of this topic, and conclude with ARRIGE members’ input on governance and public engagement initiatives.

3rd Albrecht Müller ARRIGE Seminar – Program

Introduction (2pm – 2:10pm)

  • Lluis Montoliu (ARRIGE President, Spain)

 Round table 1. Some examples of use of HGE in therapeutics (2:10 – 3:10)

  • Moderator (François Hirsch, ARRIGE Board,  France)
  • André Choulika (CEO, Cellectis, France) (2:10pm -2:30pm)
  • Deniz Dalkara (Sparing Vision, France) (2:30-2:50pm)
  • Michael Santos (F.N.I.H. & ARRIGE Scientific Committee, USA) (2:50pm-3:10pm)

Discussion (3:10pm-3:30pm)

Round table 2. Social and Ethical Implications of Genome Editing in Humans (3:30pm – 4:50pm)

  • Moderator: Jennifer Merchant (ARRIGE Board, France)
  • Alta Charo (University of Wisconsin–Madison & vice-President, ARRIGE Scientific Committee, USA) (3:30pm-3:50pm)
  • Donrich Willem Thaldar (University KwaZulu-Natal, South Africa) (3:50pm-4:10pm)
  • Katherine Littler (Global Health Ethics & Governance Unit, WHO) (4:10pm – 4:30 pm)

Discussion (4:30pm – 5pm)

General Conclusion (5pm)

  • Julian Kinderlerer (Former President, European Group on Ethics (EGE) & ARRIGE Board, South-Africa)